Literature DB >> 17355

Pharmacological basis for combination therapy of hypertension.

C T Dolley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 17355     DOI: 10.1146/annurev.pa.17.040177.001523

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


× No keyword cloud information.
  10 in total

Review 1.  Fixed-dose combination antihypertensive drugs. Do they have a role in rational therapy?

Authors:  D A Sica
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546

Review 2.  Fixed-dose combination therapy: panacea or poison?

Authors:  R B Rao; L R Goldfrank
Journal:  Intensive Care Med       Date:  1998-04       Impact factor: 17.440

Review 3.  Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats.

Authors:  Domenic A Sica
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 4.  Fixed combination drug therapy.

Authors:  G M Shenfield
Journal:  Drugs       Date:  1982-06       Impact factor: 9.546

Review 5.  Combination drug treatment of hypertension: have we come full circle?

Authors:  Addison A Taylor
Journal:  Curr Cardiol Rep       Date:  2004-11       Impact factor: 2.931

6.  Combination therapy in hypertension. A population-based study in eastern Finland.

Authors:  H Enlund; H Turakka; J Tuomilehto
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

7.  Pharmacokinetics of bendroflumethiazide alone and in combination with propranolol and hydralazine.

Authors:  M Schäfer-Korting; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

8.  Effects of the fixed combination of manidipine plus delapril in the treatment of hypertension inadequately controlled by monotherapy with either component: a phase III, multicenter, open-label, clinical trial.

Authors:  Annalisa Zoppi; Amedeo Mugellini; Paola Preti; Andrea Rinaldi; Aldo Celentano; Emma Arezzi; Marco Alberici; Roberto Fogari
Journal:  Curr Ther Res Clin Exp       Date:  2003-07

9.  Three in one: safety, efficacy, and patient acceptability of triple fixed-dose combination medicine in the management of hypertension.

Authors:  Addison A Taylor; Shawn Ragbir
Journal:  Patient Prefer Adherence       Date:  2012-08-01       Impact factor: 2.711

10.  Pharmacokinetics and drug-drug interaction between enalapril, enalaprilat and felodipine extended release (ER) in healthy subjects.

Authors:  Dai Li; Sumei Xu; Yulu Wang; Dan Li; Xiaomin Li; Jing Pan; Pingsheng Xu
Journal:  Oncotarget       Date:  2017-08-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.